Russian coronavirus vaccine to undergo preclinical tests on people aged between 18 and 60
MOSCOW, April 21. /TASS/: Russia’s Vector State Research Center of Virology and Biotechnology has formed a preliminary group of volunteers aged between 18 and 60 for preclinical trials of vaccine against the novel coronavirus, researcher Natalya Dumchenko has said.
Vector Director General Rinat Maksyutov said in early April that preclinical tests will begin in early May and last until June 22. The vaccine has already been tested on animals.